Synopsys (SNPS) Form 144: Option Exercise and Proposed 9,873-Share Sale
Rhea-AI Filing Summary
Form 144 filed for Synopsys, Inc. (SNPS) reports a proposed sale of 9,873 common shares to be executed through Morgan Stanley Smith Barney on 09/22/2025, with an aggregate market value of $4,945,407.42. The filer acquired these shares on 09/22/2025 by exercising stock options and paid in cash. The filing also discloses a prior sale by Sudhindra Kankanwadi of 6,000 shares on 09/19/2025 for $2,892,000.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Transparent disclosure of the option exercise, acquisition date, payment method, and planned sale through a broker
- Includes previous sale (6,000 shares on 09/19/2025 for $2,892,000), increasing investor visibility into insider transactions
Negative
- Insider selling activity totaling 9,873 shares (proposed) with aggregate value $4,945,407.42, which may attract investor scrutiny
- Absolute dollar size of the transactions ($~7.8M across the two disclosed sales) could be interpreted negatively by some market participants
Insights
TL;DR: Insider exercising options and filing a proposed sale of 9,873 shares valued at ~$4.95M; prior 6,000-share sale also disclosed.
The filing documents an affiliate transaction where the filer exercised options and intends to sell the resulting 9,873 shares through Morgan Stanley Smith Barney on 09/22/2025. The aggregate market value reported is $4,945,407.42. A related recent sale of 6,000 shares on 09/19/2025 generated $2,892,000. These disclosures are routine for insiders monetizing option exercises and provide transparency about timing and proceeds. Relative to the issuer's reported outstanding shares (185,748,673), the volume is immaterial as a percentage of float but is sizable in absolute dollar terms.
TL;DR: Proper Form 144 disclosure of option exercise and planned sale; contains standard certification about material non-public information.
The filer certifies no undisclosed material adverse information and records the option exercise and cash payment on the same date as the planned sale. The filing follows regulatory requirements for affiliate sales under Rule 144 and notifies the market of insider liquidity events. The presence of a recent 6,000-share sale by Sudhindra Kankanwadi is also disclosed, which together with the planned sale increases transparency about insider disposition activity.